During the past decade, LabCorp CRU, Inc. conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "LabCorp CRU, Inc." #1 sponsor was "Eli Lilly and Company" with 4 trials, followed by "Bristol-Myers Squibb" with 2 trials sponsored, "Horizon Pharma Ireland, Ltd., Dublin Ireland" with 1 trials sponsored, "Loxo Oncology, Inc." with 1 trials sponsored and "Otsuka Pharmaceutical Co., Ltd." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "LabCorp CRU, Inc." #1 collaborator was "Covance" with 2 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Loxo Oncology, Inc." with 1 trials as a collaborator and "Mars, Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "LabCorp CRU, Inc." are "Healthy" (6 trials), "ADME" (1 trials), "Drug Toxicity" (1 trials), "Gastroparesis" (1 trials) and "Healthy Participants" (1 trials). Many other conditions were trialed in "LabCorp CRU, Inc." in a lesser frequency.

Most popular intervention types in "LabCorp CRU, Inc." are "Drug" (10 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Selpercatinib" (2 trials), "(-)-[2-14C]epicatechin intake" (1 trials), "BMS-986256" (1 trials), "Controlled dietary background" (1 trials) and "HPN-100" (1 trials). Other intervention names were less common.

The vast majority of trials in "LabCorp CRU, Inc." are 5 trials for "All" genders, 5 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "LabCorp CRU, Inc.". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in LabCorp CRU, Inc., undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in LabCorp CRU, Inc., 10 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".